Novavax, Inc. (NVAX)
9.98
-0.01
(-0.10%)
USD |
NASDAQ |
Mar 06, 16:00
10.02
+0.04
(+0.40%)
After-Hours: 20:00
Novavax SG&A Expense (TTM) : 157.48M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Pfizer Inc. | 13.79B |
| Moderna, Inc. | 1.018B |
| Merck & Co., Inc. | 10.73B |
| Intellia Therapeutics, Inc. | 119.80M |
| Recursion Pharmaceuticals, Inc. | 176.59M |